| scholarly article | Q13442814 |
| P2093 | author name string | Mark Nelson | |
| Sundhiya Mandalia | |||
| Justin Stebbing | |||
| Mark Bower | |||
| Brian G Gazzard | |||
| Naa Torshie Annan | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | efavirenz | Q422645 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 140-146 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals | |
| P478 | volume | 51 |
| Q57876986 | A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study |
| Q48331724 | A randomized crossover study to compare efavirenz and etravirine treatment |
| Q24235724 | Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals |
| Q28548630 | Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia |
| Q56786269 | HIV Reverse Transcriptase Inhibitors |
| Q34737466 | Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients. |
| Q27021762 | Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis |
| Q28551476 | The Global Health Impact Index: Promoting Global Health |
| Q34433397 | The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. |
Search more.